Allergy Unit 1
1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
3. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
4. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
5. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
6. Management of anaphylaxis due to COVID-19 vaccines in the elderly
7. Management of anaphylaxis due to COVID-19 vaccines in the elderly
8. Management of anaphylaxis due to COVID-19 vaccines in the elderly
9. Management of anaphylaxis due to COVID-19 vaccines in the elderly
10. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
11. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
12. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
13. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
14. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
15. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
16. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
17. Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
18. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO
19. Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry
20. Parameters Linked With Higher Itch Severity in Chronic Spontaneous Urticaria—Chronic Urticaria Registry Results
21. Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
1